Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.

Genomic and Proteomic Biomarkers for Cardiac and Renal Transplantation: Computational Biomarker Pipeline from Discovery to Clinical Implementation
Dr. Robert McMaster, Professor, University of British Columbia, speaking at Genomics Research 2012.

Signalling Molecules as Proteomic Biomarkers in Brain Tumours
Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.

Novel Angiogenic Model Based on Stable, Fluorecently Labled Cell Lines Amenable to High Content Screening
Natalie Prigozhina, Sanford-Burnham Medical Research Institute, speaking at Cell Culture 2012

Recording Signal Transduction Dynamics With Unprecedented Temporal Resolution
Dr Jonathan West, Miniaturisation Group at ISAS, speaking at Single Cell Analysis Europe 2012.

Challenges for Stem Cell Bioprocessing - Scale-Up or Scale-Out?
Christopher Hewitt, Loughborough University, speaking at Cell Culture 2012

Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient
Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.

Companies in Translation with CIRM
Dr Alan Trounson, California Institute for Regenerative Medicine, speaking at Stem Cells 2012

In Vitro, Ex Vivo and in Models to Develop New Therapies for Renal Diseases
Frederick W. K. Tam, Imperial College London, speaking at ADME & Predictive Toxicology Europe 2012

Antibodies and Antibody RNase Fusion Proteins Targeting CD30+ Lymphoma
Thomas Schirrmann PhD, Technische Universitaet Braunschweig, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

<< 1 2 3 4 >>
Showing Results 11 - 20 of 31
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!